Roughly 75 students and community members packed into an expo-style open house in a large conference room at the Lansing ...
Tralokinumab-ldrm is approved for the treatment of moderate-to-severe AD in adult and adolescent patients 12 years and older in the European Union, Canada, Great Britain, the United Arab Emirates, ...
Springer Nature is a signatory of the San Francisco Declaration on Research Assessment (DORA). Because small numbers of highly cited articles can have outsized influence on certain citation measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results